Corrigendum on “Isorhamnetin augments the anti-tumor effect of capeciatbine through the negative regulation of NF-κB signaling cascade in gastric cancer” [Cancer Lett. 363 (1) (2015) 28–36]
- Manu, K.
- Shanmugam, M.
- Ramachandran, L.
- Li, F.
- Siveen, K.
- Chinnathambi, A.
- Zayed, M.
- Alharbi, S.
- Arfuso, Frank
- Kumar, Alan Prem
- Ahn, K.
- Sethi, G.
DOIAbstract
© 2018 The authors regret that there was a typographical error in the title of the article “Capeciatbine” should be spelled as “Capecitabine”. The authors would like to apologize for any inconvenience caused
Add to ORKG